tiprankstipranks

Arthur Tzianabos Insider Profile

4 Followers
Arthur Tzianabos, President and CSO at Tempest Therapeutics, holds 128.78K shares in Q32 Bio (Ticker: QTTB), holds 31.74K shares in Stoke Therapeutics (Ticker: STOK), holds 0.00 shares in AKOUOS (Ticker: AKUS).
tipranks
Arthur Tzianabos

Arthur Tzianabos
Tempest Therapeutics (TPST)
President and CSO

Ranked #86,346 out of 97,997 Corporate Insiders

Profitable Transactions

0%
0 out of 2 Profitable Transactions

Average Return

-66.80%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$4M
86.71%
11.81%
1.48%
A breakdown of Arthur Tzianabos's holdings

Insider Roles

Q32 Bio
(QTTB)
Director
Stoke Therapeutics
(STOK)
Director
Tempest Therapeutics
(TPST)
President and CSO
Roles that Arthur Tzianabos holds in companies

Most Profitable Insider Trade

Stock:
Tempest Therapeutics
(TPST)
Rating:Informative Buy
Date:Apr 08, 2015 - Apr 08, 2016
Return:-66.40%
The most profitable trade made by Arthur Tzianabos

Arthur Tzianabos's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Tempest Therapeutics
Dec 07, 2015
President and CSO
Uninformative Buy
$58.61K
Q32 Bio
Feb 15, 2024
Director
Uninformative Buy
12.39K
$3.44M
Stoke Therapeutics
Feb 15, 2024
Director
Uninformative Buy
69.51K
$467.83K
AKUS
AKOUOS
Dec 02, 2022
Uninformative Sell
$0.00
BINDQ
DNIB Unwind, Inc.
$0.00
List of latest transactions for each holding click on a transaction to see Arthur Tzianabos's performance on stock

Arthur Tzianabos insider profile FAQ

What is the percentage of profitable transactions made by Arthur Tzianabos?
The percentage of profitable transactions made by Arthur Tzianabos is 0%.
    What is the average return per transaction made by Arthur Tzianabos?
    The average return per transaction made by Arthur Tzianabos is -66.80%.
      What stocks does Arthur Tzianabos hold?
      Arthur Tzianabos holds: TPST, QTTB, STOK, AKUS, BINDQ stocks.
        What was Arthur Tzianabos’s latest transaction?
        Arthur Tzianabos latest transaction was an Uninformative Buy of $12.39K.
          What was Arthur Tzianabos's most profitable transaction?
          Arthur Tzianabos’s most profitable transaction was an Informative Buy of TPST stock on April 8, 2015. The return on the trade was -66.40%.
            What is Arthur Tzianabos's role in Tempest Therapeutics?
            Arthur Tzianabos's role in Tempest Therapeutics is President and CSO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.